22 June 2022
Plant Health Care plc
("Plant Health Care" or the "Company")
Result of AGM
Plant Health Care® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, announces that the resolutions put to Shareholders at the Annual General Meeting of the Company held earlier today were duly passed by way of a poll.
The Board notes that there was a significant minority who voted against Resolution 1 and the Board will engage with shareholders to understand their views. In accordance with the QCA Corporate Governance Code, to which the Company adheres, any action proposed by the Board following such engagement will be included in the Corporate Governance section of the Company's website.
The results of the poll were as follows:
|
| Resolutions | For | % | Against | % | Withheld |
| 1 | To receive, consider and approve the Company's report and audited accounts for the year ended 31 December 2021 | 134,606,744 | 77.67 | 38,703,370 | 22.33 | 40,079 |
| 2 | To re-elect Dr Christopher Richards as a director | 143,096,907 | 100 | 0 | 0 | 30,253,286 |
| 3 | To re-elect Mr Guy van Zwanenberg as a director | 173,070,767 | 99.86 | 240,426 | 0.14 | 39,000 |
| 4 | To re-appoint BDO LLP as auditor | 173,311,193 | 100 | 0 | 0 | 39,000 |
| 5 | That the Directors be authorised to agree and fix the auditor's remuneration | 173,346,193 | 100 | 0 | 0 | 4,000 |
| 6 | To authorise the directors to allot shares | 172,428,068 | 99.49 | 883,125 | 0.51 | 39,000 |
|
| Special Resolutions: | | | | | |
| 7 | To disapply the statutory pre-emption rights of the Companies Act 2006 | 172,434,547 | 99.98 | 37,532 | 0.02 | 878,114 |
| 8 | To authorise the Company to purchase its own shares | 166,615,707 | 99.96 | 70,147 | 0.04 | 6,664,339 |
The full text of each of the resolutions is set out in the Notice of AGM, available on the Company's website (www.planthealthcare.com)
| Plant Health Care plc | Tel: +1 919 926 1600 |
| Chris Richards, CEO | |
| | |
| | |
| | |
| Cenkos Securities plc - Nomad & Broker | Tel: +44 (0) 20 7397 8900 |
| Neil McDonald / Peter Lynch Vox Markets Paul Cornelius / Kat Perex
| Tel: +44 (0) 7866 384707
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
